Lake Street Advisors Group LLC bought a new stake in The Clorox Company (NYSE:CLX – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 1,632 shares of the company’s stock, valued at approximately $250,000.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Venturi Wealth Management LLC boosted its stake in Clorox by 308.5% during the 1st quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock valued at $29,000 after acquiring an additional 145 shares during the last quarter. Northwest Financial Advisors acquired a new stake in Clorox in the fourth quarter worth $29,000. Core Wealth Advisors Inc. acquired a new stake in Clorox in the fourth quarter worth $29,000. First United Bank & Trust acquired a new position in shares of Clorox during the fourth quarter valued at $31,000. Finally, GoalVest Advisory LLC bought a new position in shares of Clorox during the first quarter worth about $31,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.
Clorox Trading Up 0.9 %
Shares of Clorox stock traded up $1.15 during trading on Thursday, hitting $133.95. The stock had a trading volume of 268,155 shares, compared to its average volume of 1,225,221. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The company has a market capitalization of $16.64 billion, a PE ratio of 68.81, a P/E/G ratio of 1.96 and a beta of 0.39. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $169.14. The stock has a 50 day simple moving average of $133.80 and a 200 day simple moving average of $142.77.
Analysts Set New Price Targets
CLX has been the subject of a number of analyst reports. JPMorgan Chase & Co. reduced their target price on shares of Clorox from $158.00 to $150.00 and set a “neutral” rating for the company in a research note on Monday. Deutsche Bank Aktiengesellschaft lowered their target price on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research report on Wednesday, April 17th. BNP Paribas initiated coverage on Clorox in a research report on Monday, June 24th. They set an “underperform” rating and a $130.00 price target for the company. UBS Group lowered their price target on Clorox from $164.00 to $159.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Finally, DA Davidson reiterated a “neutral” rating and issued a $162.00 target price on shares of Clorox in a research report on Wednesday, April 17th. Six analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $142.13.
Get Our Latest Stock Report on CLX
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- Compound Interest and Why It Matters When Investing
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- Insider Buying Explained: What Investors Need to Know
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Qualcomm Stock Could Be On The Verge of an Impressive Rally
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.